Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes (2023 - 2025)

China Pharma Holdings (CPHI) has disclosed Current Taxes for 7 consecutive years, with $691677.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Taxes rose 73.26% year-over-year to $691677.0, compared with a TTM value of $691677.0 through Sep 2025, up 73.26%, and an annual FY2024 reading of $595476.0, down 42.03% over the prior year.
  • Current Taxes was $691677.0 for Q3 2025 at China Pharma Holdings, down from $741376.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $1.0 million in Q4 2023 and bottomed at $399212.0 in Q3 2024.
  • Average Current Taxes over 3 years is $668344.8, with a median of $643576.5 recorded in 2024.
  • The sharpest move saw Current Taxes plummeted 42.03% in 2024, then soared 73.26% in 2025.
  • Year by year, Current Taxes stood at $1.0 million in 2023, then plummeted by 42.03% to $595476.0 in 2024, then rose by 16.16% to $691677.0 in 2025.
  • Business Quant data shows Current Taxes for CPHI at $691677.0 in Q3 2025, $741376.0 in Q2 2025, and $555142.0 in Q1 2025.